Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial

被引：4

作者：

Chaganti, Sridhar ^{[1
]}

Maycock, Shanna ^{[2
]}

McIlroy, Graham ^{[2
]}

Iqbal, Waleed A. ^{[2
]}

Mason, John ^{[3
]}

Kanfer, Edward ^{[4
]}

Kassam, Shireen ^{[5
]}

Cwynarski, Kate ^{[6
]}

Wrench, David ^{[7
]}

Arumainathan, Arvind K. ^{[8
]}

Fox, Christopher P. ^{[9
]}

Johnson, Rod ^{[10
]}

McKay, Pam ^{[11
]}

Paneesha, Shankara ^{[12
]}

Rowntree, Clare J. ^{[13
]}

Balotis, Constantine-George ^{[14
]}

Collins, Graham P. ^{[15
]}

Davies, Andrew ^{[16
]}

Wright, Josh

Wheatley, Keith ^{[3
]}

Menne, Tobias F.

机构：

[1] Univ Hosp Birmingham NHS Fdn Trust, Ctr Clin Haematol, Birmingham, England

[2] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, England

[3] Univ Birmingham, Canc Res UK Clin Trials Unit CRCTU, Birmingham, England

[4] Hammersmith Hosp, London, England

[5] Kings Coll Hosp London, London, England

[6] Univ Coll London Hosp, Dept Haematol, London, England

[7] Guys Hosp, Guys & St Thomas NHS Fdn Trust, London, England

[8] Clatterbridge Canc Ctr, Liverpool, Merseyside, England

[9] Nottingham Univ Hosp NHS Trust, Nottingham, England

[10] St Jamess Hosp Leeds, Leeds, W Yorkshire, England

[11] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[12] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, England

[13] Univ Wales Hosp, Dept Haematol, Cardiff, Wales

[14] Leicester Royal Infirm, Leicester, England

[15] Oxford Univ Hosp NHS Fdn Trust, Oxford, England

[16] Univ Southampton, NCRI Canc Res UK Expt Canc Medicines Ctr, Fac Med, Southampton, England

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-146494

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2492

引用

页数：8